174 related articles for article (PubMed ID: 33647059)
1. Measurement of the adult human midbrain with transcranial ultrasound.
Aoun K; Double KL; Pearson-Dennett V; Yilmaz R; Berg D; Todd G
PLoS One; 2021; 16(3):e0247920. PubMed ID: 33647059
[TBL] [Abstract][Full Text] [Related]
2. Structural abnormality of substantia nigra induced by methamphetamine abuse.
Rumpf JJ; Albers J; Fricke C; Mueller W; Classen J
Mov Disord; 2017 Dec; 32(12):1784-1788. PubMed ID: 29082542
[TBL] [Abstract][Full Text] [Related]
3. Effect of Age on Substantia Nigra Hyper-echogenicity in Parkinson's Disease Patients and Healthy Controls.
Toomsoo T; Liepelt-Scarfone I; Berg D; Kerner R; Pool AH; Kadastik-Eerme L; Rubanovits I; Asser T; Taba P
Ultrasound Med Biol; 2019 Jan; 45(1):122-128. PubMed ID: 30482710
[TBL] [Abstract][Full Text] [Related]
4. Illicit stimulant use is associated with abnormal substantia nigra morphology in humans.
Todd G; Noyes C; Flavel SC; Della Vedova CB; Spyropoulos P; Chatterton B; Berg D; White JM
PLoS One; 2013; 8(2):e56438. PubMed ID: 23418568
[TBL] [Abstract][Full Text] [Related]
5. Adults with a history of illicit amphetamine use exhibit abnormal substantia nigra morphology and parkinsonism.
Todd G; Pearson-Dennett V; Wilcox RA; Chau MT; Thoirs K; Thewlis D; Vogel AP; White JM
Parkinsonism Relat Disord; 2016 Apr; 25():27-32. PubMed ID: 26923520
[TBL] [Abstract][Full Text] [Related]
6. Life-long increase of substantia nigra hyperechogenicity in transcranial sonography.
Hagenah J; König IR; Sperner J; Wessel L; Seidel G; Condefer K; Saunders-Pullman R; Klein C; Brüggemann N
Neuroimage; 2010 May; 51(1):28-32. PubMed ID: 20152909
[TBL] [Abstract][Full Text] [Related]
7. Light pigmentation phenotype is correlated with increased substantia nigra echogenicity.
Rumpf JJ; Schirmer M; Fricke C; Weise D; Wagner JA; Simon J; Classen J
Mov Disord; 2015 Nov; 30(13):1848-52. PubMed ID: 26395561
[TBL] [Abstract][Full Text] [Related]
8. Severity of restless legs syndrome is inversely correlated with echogenicity of the substantia nigra in different neurodegenerative movement disorders. a preliminary observation.
Pedroso JL; Bor-Seng-Shu E; Felicio AC; Braga-Neto P; Dutra LA; de Aquino CC; Ferraz HB; do Prado GF; Teixeira MJ; Barsottini OG
J Neurol Sci; 2012 Aug; 319(1-2):59-62. PubMed ID: 22632781
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
[TBL] [Abstract][Full Text] [Related]
10. [Usefulness of transcranial sonography in Parkinson's disease. A comparative study using 123I-FP-CIT SPECT].
Hernández Vara J; Rubiera del Fueyo M; Lorenzo Bosquet C; Castell Conesa J; Molina Cateriano CA; Rodríguez FM
Med Clin (Barc); 2008 Sep; 131(8):285-9. PubMed ID: 18803921
[TBL] [Abstract][Full Text] [Related]
11. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings.
Berg D; Siefker C; Becker G
J Neurol; 2001 Aug; 248(8):684-9. PubMed ID: 11569897
[TBL] [Abstract][Full Text] [Related]
12. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder.
Iranzo A; Stockner H; Serradell M; Seppi K; Valldeoriola F; Frauscher B; Molinuevo JL; Vilaseca I; Mitterling T; Gaig C; Vilas D; Santamaria J; Högl B; Tolosa E; Poewe W
Mov Disord; 2014 Dec; 29(14):1774-80. PubMed ID: 25384461
[TBL] [Abstract][Full Text] [Related]
13. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography.
Becker G; Seufert J; Bogdahn U; Reichmann H; Reiners K
Neurology; 1995 Jan; 45(1):182-4. PubMed ID: 7824114
[TBL] [Abstract][Full Text] [Related]
14. Sonography for diagnosis of Parkinson disease-from theory to practice: a study on 300 participants.
Alonso-Cánovas A; López-Sendón JL; Buisán J; deFelipe-Mimbrera A; Guillán M; García-Barragán N; Corral I; Matute-Lozano MC; Masjuan J; Martínez-Castrillo JC; Walter U
J Ultrasound Med; 2014 Dec; 33(12):2069-74. PubMed ID: 25425362
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the substantia nigra by means of transcranial ultrasound imaging].
Vivo-Orti MN; Tembl JI; Sastre-Bataller I; Vazquez-Costa JF; Sahuquillo P; Burguera JA
Rev Neurol; 2013 Mar; 56(5):268-74. PubMed ID: 23440754
[TBL] [Abstract][Full Text] [Related]
16. Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease.
Zhou HY; Huang P; Sun Q; Du JJ; Cui SS; Tan YY; Hu YY; Zhan WW; Wang Y; Xiao Q; Liu J; Chen SD
J Parkinsons Dis; 2018; 8(2):333-340. PubMed ID: 29614699
[TBL] [Abstract][Full Text] [Related]
17. Substantia nigra echogenicity and imaging of striatal dopamine transporters in Parkinson's disease: a cross-sectional study.
Bor-Seng-Shu E; Pedroso JL; Felicio AC; de Andrade DC; Teixeira MJ; Braga-Neto P; Batista IR; Barsottini OG; Borges V; Ferraz HB; Shih MC; Bressan RA; de Andrade LA; Walter U
Parkinsonism Relat Disord; 2014 May; 20(5):477-81. PubMed ID: 24629800
[TBL] [Abstract][Full Text] [Related]
18. Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.
Ahmadi SA; Bötzel K; Levin J; Maiostre J; Klein T; Wein W; Rozanski V; Dietrich O; Ertl-Wagner B; Navab N; Plate A
Neuroimage Clin; 2020; 26():102185. PubMed ID: 32050136
[TBL] [Abstract][Full Text] [Related]
19. Substantia nigra echogenicity correlated with clinical features of Parkinson's disease.
Zhou HY; Sun Q; Tan YY; Hu YY; Zhan WW; Li DH; Wang Y; Xiao Q; Liu J; Chen SD
Parkinsonism Relat Disord; 2016 Mar; 24():28-33. PubMed ID: 26842545
[TBL] [Abstract][Full Text] [Related]
20. Transcranial sonography of the substantia nigra: digital image analysis.
Skoloudík D; Jelínková M; Blahuta J; Cermák P; Soukup T; Bártová P; Langová K; Herzig R
AJNR Am J Neuroradiol; 2014 Dec; 35(12):2273-8. PubMed ID: 25059698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
